期刊文献+

胆汁酸代谢异常与肠易激综合征相关性研究 被引量:5

Correlation study between bile acid metabolism and irritable bowel syndrome
下载PDF
导出
摘要 肠易激综合征(irritable bowel syndrome,IBS)是一种以腹痛或腹部不适伴排便习惯和粪便性状改变为主要表现的胃肠功能紊乱性疾病,临床上根据排便特点和粪便的性状可分为腹泻型、便秘型和混合型。IBS的发生与胆汁酸代谢密切相关,胆汁酸具有促进结肠运动的功能,胆汁酸产生过多、重吸收减少会导致腹泻发生,相反,胆汁酸产生过少、重吸收增加则会引起便秘。与健康人群相比,IBS患者在粪便胆汁酸含量、血清C4水平、结肠运动频率等方面均有显著改变。治疗胆汁酸相关性IBS的思路主要在于调节胆汁酸代谢,通过负反馈机制直接调节胆汁酸的分泌,或通过胆汁酸转运机制影响胆汁酸的重吸收率,或间接通过调节益生菌恢复胆汁酸代谢都是治疗IBS的有效机制。 Irritable bowel syndrome(IBS) is a common disease of intestinal disorder. It is characterized by abdominal pain or discomfort along with altered bowel movement characteristics and the excrement character. It can be divided into diarrhea-predominant type,constipation-predominant type and mixed type according to the bowel movement characteristics and the excrement character. IBS is closely related to the metabolism of bile acid. Bile acid can accelerate the movement of colon. Overmuch production or reduction of reabsorption of bile acid will lead to diarrhea. On the contrary,insufficient production or too much reabsorption will lead to constipation. Compared with healthy people,IBS patients have significant changes in the colon movement frequency,content and proportion of stool bile acid and level of serum C4. The treatment of bile acid-related IBS aims at regulating the metabolism of bile acid. Directly regulating the secretion of bile acid via negative feedback,or affecting the reabsorption rate,or indirectly renewing the metabolism of bile acid are effective ways to treat IBS.
出处 《胃肠病学和肝病学杂志》 CAS 2017年第1期110-113,共4页 Chinese Journal of Gastroenterology and Hepatology
基金 北京市高层次卫生技术人才培养计划(2013-3-024)
关键词 胆汁酸 肠易激综合征 腹泻 便秘 Bile acid Irritable bowel syndrome Diarrhea Constipation
  • 相关文献

参考文献4

二级参考文献62

  • 1Yan-Yan Dong, Xiu-Li Zuo, Chang-Qing Li, Yan-Bo Yu, QiuJie Zhao, Yan-Qing Li.Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome Ⅲ criteria[J].World Journal of Gastroenterology,2010,16(33):4221-4226. 被引量:23
  • 2Shahid S, Ramzan Z, Maurer AH, Parkman HP, Fisher RS.Chronic idiopathic constipation: more than a simple colonictransit disorder. J Clin Gastroenterol 2012; 46: 150-154 [PMID:22011587 DOI: 10.1097/MCG.0b013e318231fc64].
  • 3Dai C, Zheng CQ, Jiang M, Ma XY, Jiang LJ. Probiotics andirritable bowel syndrome. World J Gastroenterol 2013; 19:5973-5980 [PMID: 24106397 DOI: 10.3748/wjg.v19.i36.5973].
  • 4Lovell RM, Ford AC. Global prevalence of and risk factors forirritable bowel syndrome: a meta-analysis. Clin GastroenterolHepatol 2012; 10: 712-721.e4 [PMID: 22426087 DOI: 10.1016/j.cgh.2012.02.029].
  • 5Andresen V, Camilleri M, Busciglio IA, Grudell A, Burton D,McKinzie S, Foxx-Orenstein A, Kurtz CB, Sharma V, Johnston JM,Currie MG, Zinsmeister AR. Effect of 5 days linaclotide on transitand bowel function in females with constipation-predominantirritable bowel syndrome. Gastroenterology 2007; 133: 761-768[PMID: 17854590].
  • 6Frissora CL, Koch KL. Symptom overlap and comorbidity ofirritable bowel syndrome with other conditions. Curr GastroenterolRep 2005; 7: 264-271 [PMID: 16042909 DOI: 10.1007/s11894-005-0018-9].
  • 7Liu J, Hou X. A review of the irritable bowel syndromeinvestigation on epidemiology, pathogenesis and pathophysiologyin China. J Gastroenterol Hepatol 2011; 26 Suppl 3: 88-93 [PMID:21443718 DOI: 10.1111/j.1440-1746.2011.06641.x].
  • 8Schoenfeld PS. New treatment option for irritable bowelsyndrome with constipation and chronic idiopathic constipation.Gastroenterol Hepatol (N Y) 2012; 8: 825-828 [PMID: 24693271].
  • 9Bajor A, Gillberg PG, Abrahamsson H. Bile acids: short and longterm effects in the intestine. Scand J Gastroenterol 2010; 45:645-664 [PMID: 20334475 DOI: 10.3109/00365521003702734].
  • 10Mozaffari S, Nikfar S, Abdollahi M. The safety of novel drugsused to treat irritable bowel syndrome. Expert Opin Drug Saf 2014;13: 625-638 [PMID: 24669839 DOI: 10.1517/14740338.2014.902932].

共引文献66

同被引文献58

引证文献5

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部